Literature DB >> 3158769

Interaction of 5-hydroxytryptamine and ketanserin in rat vas deferens subjected to low frequency field stimulation.

A Karasawa, K Kubo, K Shuto, N Nakamizo.   

Abstract

The interaction of 5-hydroxytryptamine (5HT) and ketanserin was investigated in isolated rat vas deferens. Ketanserin (10(-7) M) almost completely abolished the phasic and the following rhythmic contractions induced by 5HT, whereas the inhibition by prazosin (10(-6) M) or methysergide (10(-6) M) of 5HT-induced contractions were incomplete. The amplitude of twitch contractions of vas deferens subjected to low frequency (0.1 Hz) field stimulation were substantially unchanged by 5HT (10(-7)-10(-5) M) per se. After pretreatment of the tissue with ketanserin (10(-8)-10(-6) M), 5HT, in a concentration-dependent manner, attenuated the amplitude of twitch contractions. Such attenuation of the amplitude was not observed after pretreatments with methysergide (10(-8)-10(-6) M) or prazosin (10(-7)-10(-5) M). The 5HT-induced inhibition of twitch contractions in the presence of ketanserin was not antagonized by phentolamine, propranolol, methysergide, morphine, promethazine, cimetidine, atropine or indomethacin. It is suggested that 5HT has dual (excitatory and inhibitory) effects upon nerve transmission of rat vas deferens, and only the excitatory effect is suppressed by ketanserin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158769     DOI: 10.1254/jjp.37.285

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens.

Authors:  M Borton; J R Docherty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Cyclohexylamine, an active compound from Toddalia asiatica, contracts epididymal vas deferens via serotonergic receptors.

Authors:  Yuh-Fung Chen; Yu-Wen Wang; Ih-Sheng Chen; Huei-Yann Tsai
Journal:  Biomedicine (Taipei)       Date:  2020-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.